🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Roche said it plans a Phase 3 trial testing prasinezumab for early-stage Parkinson’s, following encouraging data from other studies. buff.ly/223zZ9l

People with Parkinson's can have trouble identifying emotions, an idea that has columnist Mary Beth Skylis looking at her father anew. buff.ly/bsB9niu

Researchers examined bacteria from Parkinson’s patients to explore the role of gut and oral microbiomes in cognitive impairment. buff.ly/b5oK0c3

The NLRP3 inhibitor VTX3232 met its primary goal in a Parkinson's trial, being found safe and well tolerated among early-stage patients. buff.ly/BUxRDc1

A new method that uses artificial intelligence to analyze the smell in earwax ultimately might be able to aid in detecting Parkinson’s. buff.ly/PAVjk8i

Columnist Mollie Lombardi adapted David Letterman's "Stupid Human Tricks" to praise the small victories in her own life with Parkinson's. buff.ly/xqAanfH

A grant will allow a Canadian researcher to investigate how a recently found mutation in the RAB32 gene is linked to Parkinson’s disease. buff.ly/kWxAsk6

Columnist Doc Irish pays tribute to his dog, Jax, in a reflection on aging that also looks at his own life with Parkinson's disease. buff.ly/AZMPBnA

Parkinson's patients have altered levels of certain fat molecules in their brains, which may play a role in disease development, per a study. parkinsonsnewstoday.com/news/levels-fa…

Neuron23 has dosed the first participant in a Phase 2 clinical trial of NEU-411, its candidate therapy for LRRK2-driven early Parkinson’s. buff.ly/us4ljOZ

Although Parkinson's requires columnist Christine Scheer to slow down, she's grateful her loved ones are patient and understanding. buff.ly/jsC2DA6

Copper supplementation reduced the signs and symptoms of Parkinson's disease in a mouse model, a study showed. buff.ly/fS8BUiV

Receiving the same love before and after her Parkinson's diagnosis reminds columnist Mollie Lombardi what friends are for. parkinsonsnewstoday.com/columns/living…

Columnist Jamie Askari is working on being less controlling in her marriage. As her husband likes to say, "It's progress, not perfection." buff.ly/OhoIeOp

A trio of major Parkinson's disease advocacy groups is calling on the U.S. federal government to provide strong funding for the NIH. parkinsonsnewstoday.com/news/parkinson…

BioVie’s clinical trial of bezisterim in early Parkinson’s uses a hybrid approach to center patient experience and promote accessibility. buff.ly/0nwLtJf

Even before experiencing symptoms, Parkinson’s patients show increased immune activity, with higher T-cell levels, a new study reports. buff.ly/ReeCU07

Columnist Mollie Lombardi is excited to begin her journey with the newly approved adaptive DBS system, which adjusts based on her brain waves. buff.ly/Sh5TpLH

Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease. buff.ly/1TKMKRR

The FDA plans to make a decision on Aug. 9 regarding a ketamine-based product that Pharmather hopes to investigate for Parkinson's dyskinesia. parkinsonsnewstoday.com/news/pharmathe…